Enhancement of the function of neutrophil type-1 and type-3 complement receptors by human leukocyte inhibitory factor (LIF)

1988 ◽  
Vol 113 (2) ◽  
pp. 320-328 ◽  
Author(s):  
Larry Borish ◽  
Carmen Audera ◽  
Raymond Rosenbaum ◽  
Ross E. Rocklin
2020 ◽  
Vol 218 ◽  
pp. 107970
Author(s):  
Cássio Marinho Campelo ◽  
Igor Carvalho Pinheiro ◽  
Bruno de Melo Tavares ◽  
Guilherme Alves de Lima Henn ◽  
Camila Fernandes ◽  
...  

Author(s):  
Shinya Makino ◽  
Takeshi Uchihashi ◽  
Yasuo Kataoka ◽  
Masayoshi Fujiwara

Summary Recovery from alopecia is rare in autoimmune polyglandular syndrome (APS). A 41-year-old male was admitted to our hospital with hyperglycemia. He developed alopecia areata (AA) 5 months before admission and developed thirst, polyuria, and anorexia in 2 weeks. His plasma glucose level upon admission was 912 mg/dl (50.63 mmol/l) and HbA1c was 13.7%. Although urinary and plasma C-peptide levels showed that insulin secretion was not depleted, anti-insulinoma-associated antigen 2 antibody was present. In addition, measurement of thyroid autoantibodies revealed the presence of Hashimoto's thyroiditis. These findings suggested a diagnosis of APS type 3. The patient has showed signs of improvement with the continuation of insulin therapy. During the successful control of diabetes, he had total hair regrowth within 2–3 months. Human leukocyte antigen typing showed that DRB1*1501-DQB1*0602 and DQB1*0301 were present. Similar cases should be accumulated to clarify the association of APS type 3 with recovery from AA. Learning points Alopecia in diabetic patients is a suspicious manifestation of autoimmune type 1 diabetes. Patients with autoimmune type 1 diabetes specifically manifesting alopecia should be further examined for diagnosis of APS. Insulin-mediated metabolic improvement may be a factor, but not the sole factor, determining a favorable outcome of alopecia in patients with autoimmune type 1 diabetes.


1988 ◽  
Vol 81 (1) ◽  
pp. 233 ◽  
Author(s):  
Helio Schainberg ◽  
Larry Borish ◽  
Michael King ◽  
Lanny J. Rosenwasser ◽  
Ross E. Rocklin

1978 ◽  
Vol 1 (1) ◽  
pp. 57-69 ◽  
Author(s):  
B.A. Maurer ◽  
D.F. Siwarski ◽  
G.P. Fischetti ◽  
J.L. McCoy ◽  
J.H. Dean ◽  
...  

Inflammation ◽  
1988 ◽  
Vol 12 (3) ◽  
pp. 203-211
Author(s):  
Helio Schainberg ◽  
Larry Borish ◽  
Ross E. Rocklin

1985 ◽  
Vol 231 (1) ◽  
pp. 233-236 ◽  
Author(s):  
K J Micklem ◽  
R B Sim

The proteins from labelled human spleen membranes and polymorphonuclear leucocytes which bind to the iC3b fragment of complement component C3 were prepared by iC3b-Sepharose chromatography in the presence of bivalent cations. Complement receptor type 3(CR3) was eluted from iC3b-Sepharose by removal of bivalent cations. Complement receptors type 1 and 2 (present in spleen but not in polymorphonuclear leucocytes) were sequentially eluted by an NaCl gradient. An additional protein of Mr 135 000 was eluted from iC3b-Sepharose under the same conditions as those used to elute CR3. Preabsorption of the starting material on an anti-(CR3 β-subunit) antibody column before iC3b-Sepharose chromatography removed the α- and β-chains of CR3 and the 135 000-Mr protein. Preabsorption with iC3b-Sepharose before the anti-(CR3 β-subunit) antibody column showed that iC3b binds CR3 and p150,95, the smallest member of the group of three homologous proteins that share the same β-subunit.


Sign in / Sign up

Export Citation Format

Share Document